Characterization of Systemic and Culprit-Coronary Artery miR-483-5p Expression in Chronic CAD and Acute Myocardial

Olga Volodko1,2, Natalia Volinsky1, Merav Yarkoni3

  • 1The Lydia and Carol Kittner, Lea and Benjamin Davidai Division of Cardiovascular Medicine and Surgery and Research Institute, Tzafon Medical Center, Affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Tiberias 1528001, Israel.

Insights

MicroRNA-483-5p shows a distinct coronary arterial gradient in acute myocardial infarction patients, differing from chronic coronary artery disease. This microRNA may serve as a biomarker and therapeutic target for cardiovascular diseases.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Genomics

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Aberrant microRNA (miRNA) levels in circulation impact gene expression and pathophysiology in chronic and acute myocardial infarction (MI) states.

Purpose of the Study:

  • To compare microRNA expression profiles in peripheral blood versus coronary arteries of male patients with chronic CAD and acute MI.
  • To investigate the role of microRNA-483-5p (miR-483-5p) as a potential biomarker and therapeutic target in cardiovascular disease.

Main Methods:

  • Blood samples were collected from peripheral arteries and proximal coronary arteries during coronary catheterization from chronic-CAD, acute-MI (STEMI/NSTEMI), and control patients.
  • RNA extraction, miRNA library preparation, and Next Generation Sequencing were performed.
  • In silico gene target analysis was conducted for miR-483-5p.

Main Results:

  • A significant 'coronary arterial gradient' of miR-483-5p was observed in acute MI patients compared to chronic CAD patients (p = 0.035) and controls versus chronic CAD (p < 0.001).
  • Peripheral miR-483-5p was downregulated in both acute MI and chronic CAD patients compared to controls (p < 0.005).
  • Receiver operating characteristic curve analysis indicated miR-483-5p's association with chronic CAD (AUC = 0.722, p < 0.001), with 79% sensitivity and 70% specificity.

Conclusions:

  • The high miR-483-5p coronary arterial gradient in acute MI suggests localized mechanisms in response to myocardial ischemia.
  • MiR-483-5p targets genes involved in inflammation, oxidative stress, apoptosis, fibrosis, angiogenesis, and wound healing.
  • MiR-483-5p is a potential biomarker and therapeutic target for acute and chronic cardiovascular diseases.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
17
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
24
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34